Generating Off-the-Shelf Hematopoietic Stem Cells by "Stretching" Induced Pluripotent Stem Cells.

References:

• J. R. Passweg, H. Baldomero, F. Ciceri, et al., “Hematopoietic Cell Transplantation and Cellular Therapies in Europe 2021. The Second Year of the SARS‐CoV‐2 Pandemic. A Report From the EBMT Activity Survey,” Bone Marrow Transplantation 58, no. 6 (2023): 647–658.
• S. Bastani, F. J. T. Staal, and K. Cante‐Barrett, “The Quest for the Holy Grail: Overcoming Challenges in Expanding Human Hematopoietic Stem Cells for Clinical Use,” Stem Cell Investigation 10, no. 15 (2023): 15, https://doi.org/10.21037/sci‐2023‐016.
• Z. Li, S. M. Rubinstein, R. Thota, et al., “Immune‐Mediated Complications After Hematopoietic Stem Cell Transplantation,” Biology of Blood and Marrow Transplantation 22, no. 8 (2016): 1368–1375.
• Y. Wang and R. Sugimura, “Ex Vivo Expansion of Hematopoietic Stem Cells,” Experimental Cell Research 427, no. 1 (2023): 113599.
• N. Uchida, A. Leonard, D. Stroncek, et al., “Safe and Efficient Peripheral Blood Stem Cell Collection in Patients With Sickle Cell Disease Using Plerixafor,” Haematologica 105, no. 10 (2020): e497.